Related references
Note: Only part of the references are listed.Antihypertensive treatment and risk of atrial fibrillation: a nationwide study
Sarah C. W. Marott et al.
EUROPEAN HEART JOURNAL (2014)
Incidence of atrial fibrillation in a population with impaired glucose tolerance: The contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial
Roberto Latini et al.
AMERICAN HEART JOURNAL (2013)
Effect of Amlodipine on the Survival of Patients With Severe Chronic Heart Failure Due to a Nonischemic Cardiomyopathy Results of the PRAISE-2 Study (Prospective Randomized Amlodipine Survival Evaluation 2)
Milton Packer et al.
JACC-HEART FAILURE (2013)
The Global Burden of Atrial Fibrillation and Stroke A Systematic Review of the Epidemiology of Atrial Fibrillation in Regions Outside North America and Europe
Gregory Y. H. Lip et al.
CHEST (2012)
Antiarrhythmic Drug Therapy for Atrial Fibrillation
Peter Zimetbaum
CIRCULATION (2012)
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Christopher J. L. Murray et al.
LANCET (2012)
Effect of Statins on Venous Thromboembolic Events: A Meta-analysis of Published and Unpublished Evidence from Randomised Controlled Trials
Kazem Rahimi et al.
PLOS MEDICINE (2012)
Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention
Irene Savelieva et al.
EUROPACE (2011)
Irbesartan in Patients with Atrial Fibrillation
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials
Kazem Rahimi et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Guidelines for the management of atrial fibrillation The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
A. John Camm et al.
EUROPACE (2010)
Prevention of Atrial Fibrillation by Renin-Angiotensin System Inhibition A Meta-Analysis
Markus P. Schneider et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs
Janice Pogue et al.
CLINICAL TRIALS (2009)
Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study
Xin Du et al.
EUROPEAN HEART JOURNAL (2009)
Atrial Fibrillation at Baseline and During Follow-Up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)
L. Julian Haywood et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial
Paolo Verdecchia et al.
LANCET (2009)
Valsartan for Prevention of Recurrent Atrial Fibrillation
Marcello Disertori et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati et al.
PLOS MEDICINE (2009)
Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
M. R. Law et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
atrial fibrillation and isolated Systolic hypertension: The systolic hypertension in the elderly program and Systolic hypertension in the elderly program-extension study
Tudor D. Vagaonescu et al.
HYPERTENSION (2008)
Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial
Roland E. Schmieder et al.
JOURNAL OF HYPERTENSION (2008)
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial
S. Yusuf et al.
LANCET (2008)
Telmisartan, ramipril, or both in patients at high risk for vascular events
Salim Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Telmisartan to prevent recurrent stroke and cardiovascular events
Salim Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Coronary artery disease - Impact of ramipril on the incidence of atrial fibrillation: Results of the Heart Outcomes Prevention Evaluation study
Omid Salehian et al.
AMERICAN HEART JOURNAL (2007)
Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis
Imad Abi Nasr et al.
EUROPEAN HEART JOURNAL (2007)
Presence and development of atrial fibrillation in chronic heart failure - Experiences from the MERIT-HF Study
Dirk J. van Veldhuisen et al.
EUROPEAN JOURNAL OF HEART FAILURE (2006)
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program
Anique Ducharme et al.
AMERICAN HEART JOURNAL (2006)
Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers - A meta-analysis
JS Healey et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol -: The Losartan Intervention For End point reduction in hypertension (LIFE) study
K Wachtell et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Valsartan reduces the incidence of atrial fibrillation in patients with heart failure:: Results from the Valsartan Heart Failure Trial (Val-HeFT)
AP Maggioni et al.
AMERICAN HEART JOURNAL (2005)
Antiarrhythmic effect of carvedilol after acute myocardial infarction - Results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial
J McMurray et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAL experience
M Lehto et al.
EUROPEAN HEART JOURNAL (2005)
Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin:: randomised, double blind, placebo controlled trial (the DIABHYCAR study)
M Marre et al.
BRITISH MEDICAL JOURNAL (2004)
Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction - Insight from the studies of left ventricular dysfunction (SOLVD) trials
E Vermes et al.
CIRCULATION (2003)
Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data
F Pizzetti et al.
HEART (2001)
Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial
HJ Dargie et al.
LANCET (2001)
Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension:: the Nordic Diltiazem (NORDIL) study
L Hansson et al.
LANCET (2000)
Share Paper
